CGON · CG Oncology, Inc. · Executive Compensation
$80.47
-1.44 (-1.75%)
At close · Nov 20
Return incl. dividend (before tax)
Market Cap
$7.32B
Shares
89.32M
Volume · Nov 20
607.54K
Avg daily vol (3M)
1.21M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Arthur Kuan | Chief Executive Officer | $11,928,401 |
| Ambaw Bellete | President and Chief Operating Officer | $4,815,391 |
| Vijay Kasturi | Chief Medical Officer | $3,599,947 |
| Joshua F. Patterson | General Counsel, Chief Compliance Officer, and Secretary | $2,364,380 |
| Corleen M. Roche | Prior Chief Financial Officer | $2,322,299 |
| Jim DeTore | Chief Financial Officer | $96,000 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Arthur Kuan | Chief Executive Officer | $11,172,793 |
| Corleen M. Roche | Chief Financial Officer | $9,845,800 |
| Ambaw Bellete | President and Chief Operating Officer | $5,241,391 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Arthur Kuan | Chief Executive Officer | $3,933,996 |
| Ambaw Bellete | President and Chief Operating Officer | $3,029,535 |
| Corleen M. Roche | Chief Financial Officer | — |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Arthur Kuan | President | Appointed | 2026-05-26 |
| Jim DeTore | Chief Financial Officer | Appointed | 2026-04-13 |
|
Simone Song
“Ms. Song’s resignation was not the result of any disagreement with the Company.”
|
Board | Resigned | 2025-11-26 |
| Christina Rossi | Class II director | Appointed | 2025-11-26 |
| Jim DeTore | interim principal financial and accounting officer | Appointed | 2025-11-14 |
| Robert Lapetina | interim principal financial and accounting officer | Resigned | 2025-11-14 |
| Robert Lapetina | principal financial and accounting officer | Appointed | 2025-07-11 |
| Corleen Roche | Chief Financial Officer | Resigned | 2025-07-11 |
Leadership
- Arthur Kuan CEO
- Corleen M. Roche CFO
- Jim DeTore CFO
- Ambaw Bellete COO
- Joshua F. Patterson General Counsel
- Robert Lapetina Chief Accounting Officer
- Christina Rossi Board Member
- Victor Tong Board Member
Key facts
CIK
1991792
CUSIP
156944100
13F (30d)
239 filings
224 filers
Visit website
Investor relations